178 related articles for article (PubMed ID: 18089450)
1. Relationship between fetuin-A concentration, elevated levels of inflammatory markers, and arterial wall stiffness in end-stage kidney disease.
Kuźniar J; Porazko T; Klinger M
J Ren Nutr; 2008 Jan; 18(1):83-6. PubMed ID: 18089450
[TBL] [Abstract][Full Text] [Related]
2. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.
Hermans MM; Brandenburg V; Ketteler M; Kooman JP; van der Sande FM; Gladziwa U; Rensma PL; Bartelet K; Konings CJ; Hoeks AP; Floege J; Leunissen KM
Nephrol Dial Transplant; 2006 May; 21(5):1293-9. PubMed ID: 16396973
[TBL] [Abstract][Full Text] [Related]
3. IL-18 is involved in vascular injury in end-stage renal disease patients.
Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
[TBL] [Abstract][Full Text] [Related]
4. Increased aortic wall stiffness associated with low circulating fetuin A and high C-reactive protein in predialysis patients.
Porazko T; Kuźniar J; Kusztal M; Kuźniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
Nephron Clin Pract; 2009; 113(2):c81-7. PubMed ID: 19602903
[TBL] [Abstract][Full Text] [Related]
5. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients.
Wang AY; Woo J; Lam CW; Wang M; Chan IH; Gao P; Lui SF; Li PK; Sanderson JE
Nephrol Dial Transplant; 2005 Aug; 20(8):1676-85. PubMed ID: 15899935
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.
Guérin AP; Pannier B; Marchais SJ; London GM
Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):105-10. PubMed ID: 16481874
[TBL] [Abstract][Full Text] [Related]
7. Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4.
Ford ML; Tomlinson LA; Smith ER; Rajkumar C; Holt SG
Nephrol Dial Transplant; 2010 Jun; 25(6):1853-8. PubMed ID: 20075438
[TBL] [Abstract][Full Text] [Related]
8. Cardiac calcifications: Fetuin-A and other risk factors in hemodialysis patients.
Coen G; Manni M; Agnoli A; Balducci A; Dessi M; De Angelis S; Jankovic L; Mantella D; Morosetti M; Naticchia A; Nofroni I; Romagnoli A; Gallucci MT; Tomassini M; Simonetti G; Splendiani G
ASAIO J; 2006; 52(2):150-6. PubMed ID: 16557100
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients.
Jung JY; Hwang YH; Lee SW; Lee H; Kim DK; Kim S; Oh YG; Yang J; Joo KW; Ahn C; Oh KH
Nephrol Dial Transplant; 2010 Dec; 25(12):4041-8. PubMed ID: 20501463
[TBL] [Abstract][Full Text] [Related]
10. Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients.
Toussaint ND; Polkinghorne KR; Kerr PG
Hemodial Int; 2008 Apr; 12(2):254-63. PubMed ID: 18394060
[TBL] [Abstract][Full Text] [Related]
11. Vascular calcification and fetuin-A deficiency in chronic kidney disease.
Westenfeld R; Jahnen-Dechent W; Ketteler M
Trends Cardiovasc Med; 2007 May; 17(4):124-8. PubMed ID: 17482094
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection as a risk factor for increased aortic stiffness and cardiovascular events in dialysis patients.
Oyake N; Shimada T; Murakami Y; Ishibashi Y; Satoh H; Suzuki K; Matsumory A; Oda T
J Nephrol; 2008; 21(3):345-53. PubMed ID: 18587722
[TBL] [Abstract][Full Text] [Related]
13. Vascular calcification in patients with end-stage renal disease.
Floege J; Ketteler M
Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V59-66. PubMed ID: 15284362
[TBL] [Abstract][Full Text] [Related]
14. Fetuin-A and arterial stiffness in patients with normal kidney function.
Roos M; Richart T; Kouznetsova T; von Eynatten M; Lutz J; Heemann U; Baumann M; Staessen JA
Regul Pept; 2009 Apr; 154(1-3):39-43. PubMed ID: 19110009
[TBL] [Abstract][Full Text] [Related]
15. Serum osteoprotegerin level, carotid-femoral pulse wave velocity and cardiovascular survival in haemodialysis patients.
Speer G; Fekete BC; El Hadj Othmane T; Szabó T; Egresits J; Fodor E; Kiss I; Logan AG; Nemcsik J; Szabó A; Németh ZK; Szathmári M; Tislér A
Nephrol Dial Transplant; 2008 Oct; 23(10):3256-62. PubMed ID: 18450827
[TBL] [Abstract][Full Text] [Related]
16. Arterial stiffness: a new surrogate end point for cardiovascular disease?
Laurent S; Boutouyrie P
J Nephrol; 2007; 20 Suppl 12():S45-50. PubMed ID: 18050143
[TBL] [Abstract][Full Text] [Related]
17. Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.
Metry G; Stenvinkel P; Qureshi AR; Carrero JJ; Yilmaz MI; Bárány P; Snaedal S; Heimbürger O; Lindholm B; Suliman ME
Eur J Clin Invest; 2008 Nov; 38(11):804-11. PubMed ID: 19021697
[TBL] [Abstract][Full Text] [Related]
18. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?
Pertosa G; Simone S; Ciccone M; Porreca S; Zaza G; Dalfino G; Memoli B; Procino A; Bonomini M; Sirolli V; Castellano G; Gesualdo L; Ktena M; Schena FP; Grandaliano G
Am J Kidney Dis; 2009 Mar; 53(3):467-74. PubMed ID: 19167798
[TBL] [Abstract][Full Text] [Related]
19. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease.
Sigrist MK; Taal MW; Bungay P; McIntyre CW
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1241-8. PubMed ID: 17928470
[TBL] [Abstract][Full Text] [Related]
20. Pulse wave velocity in end-stage renal disease: influence of age and body dimensions.
Kis E; Cseprekál O; Horváth Z; Katona G; Fekete BC; Hrapka E; Szabó A; Szabó AJ; Fekete A; Reusz GS
Pediatr Res; 2008 Jan; 63(1):95-8. PubMed ID: 18043514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
